Log in
NYSE:AZN

AstraZeneca Price Target, Predictions & Analyst Ratings

$52.61
+0.01 (+0.02 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$51.44
Now: $52.61
$52.77
50-Day Range
$50.16
MA: $53.81
$58.02
52-Week Range
$36.15
Now: $52.61
$64.94
Volume14.74 million shs
Average Volume5.24 million shs
Market Capitalization$138.08 billion
P/E Ratio63.39
Dividend Yield1.67%
Beta0.5

Analyst Ratings

AstraZeneca (NYSE:AZN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
11 Wall Street analysts have issued ratings and price targets for AstraZeneca in the last 12 months. Their average twelve-month price target is $61.67, predicting that the stock has a possible upside of 17.21%. The high price target for AZN is $65.00 and the low price target for AZN is $60.00. There are currently 2 sell ratings, 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
AZN Consensus Rating: HoldBuyHoldHold
AZN Consensus Rating Score: 2.452.502.092.33
AZN Analyst Ratings: 2 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
AZN Consensus Price Target: $61.67$61.67$61.67$60.00
AZN Price Target Upside: 17.21% upside17.87% upside17.87% upside18.50% upside

AstraZeneca (NYSE:AZN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

AstraZeneca (NYSE:AZN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/23/2020Morgan StanleyReiterated RatingEqual WeightMedium
11/11/2020HSBCUpgradeReduce ➝ HoldLow
9/29/2020Berenberg BankInitiated CoverageBuyLow
9/23/2020Oddo BhfUpgradeReduce ➝ BuyLow
7/29/2020BarclaysReiterated RatingOverweightLow
6/10/2020CowenBoost Price Target$55.00 ➝ $60.00Low
6/4/2020UBS GroupReiterated RatingSellLow
5/29/2020GuggenheimReiterated RatingBuyMedium
5/29/2020SVB LeerinkBoost Price TargetOutperform$60.00 ➝ $65.00Low
5/6/2020ArgusBoost Price TargetBuy$54.00 ➝ $60.00Low
4/23/2020FIG PartnersInitiated CoverageReduceLow
10/24/2019Liberum CapitalReiterated RatingHold ➝ HoldLow
9/3/2019DZ BankDowngradeHold ➝ SellLow
4/29/2019Pareto SecuritiesUpgradeSell ➝ HoldLow
3/19/2019Main First BankReiterated RatingBuyLow
2/26/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
2/26/2019The Goldman Sachs GroupReiterated RatingSellLow
2/5/2019Exane BNP ParibasInitiated CoverageOutperformLow
1/15/2019BMO Capital MarketsReiterated RatingBuy$48.00Medium
12/14/2018Bank of AmericaReiterated RatingBuyLow
12/13/2018SunTrust BanksInitiated CoverageBuy$48.00Low
12/11/2018Jefferies Financial GroupReiterated RatingHold ➝ Hold$42.00Medium
12/9/2018Credit Suisse GroupReiterated RatingBuyLow
11/19/2018InvestecDowngradeBuy ➝ HoldMedium
10/23/2018Wolfe ResearchInitiated CoverageOutperformLow
6/12/2018MorningstarReiterated RatingHoldLow
2/5/2018Sanford C. BernsteinBoost Price TargetOutperform$40.00 ➝ $42.00High
12/29/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightLow
(Data available from 11/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.